HR948: HR948 House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications; create
Last action March 9, 2026 · House Passed/Adopted By Substitute
A Georgia House resolution creates a study committee to examine pharmacy benefits managers and their effect on patients' access to prescription drugs, with a report due before the committee ends on December 1, 2026.
In plain language
Pharmacy benefits managers (PBMs) are companies that administer prescription drug coverage, negotiate with drug makers and pharmacies, and set which drugs insurance will cover. This resolution notes that drug prices have risen faster than inflation and that PBMs have faced criticism for steering patients to pharmacies they own, marking up drug costs, and manipulating pharmacy reimbursement rates, practices some say have contributed to counties in Georgia losing their only pharmacy. The resolution creates the House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications. It sets the committee's membership, meeting process, and reimbursement rules, and directs it to study these issues and recommend legislation if needed. The committee must file any approved report before it is abolished on December 1, 2026.
What the bill does
- Creates the House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications to examine PBM practices.
- Sets the committee's membership: the chairs of the House Appropriations and Health committees, three more appointees chosen by the Speaker, and a chairperson designated by the Speaker.
- Directs the committee to study PBM related problems and recommend any legislation or action it deems necessary.
- Establishes daily expense allowances and mileage reimbursement for legislative and non-legislative committee members, capped at five days unless extended.
- Requires any approved findings or recommendations to be filed as a report with the Clerk of the House before the committee is abolished.
- Abolishes the committee automatically on December 1, 2026.
Who it affects
The resolution directly affects members of the House Appropriations and Health committees, Speaker-appointed legislators or experts on pharmacy issues, and indirectly touches pharmacy benefits managers, independent and PBM-affiliated pharmacies, and Georgia patients who rely on prescription drug coverage.
Why it matters
The committee's work could shape future legislation on how pharmacy benefits managers set drug prices and steer patients to certain pharmacies, an issue tied to rising drug costs and the loss of pharmacies in some Georgia counties, though the resolution itself makes no binding policy changes.
Key provisions
- Paragraph 1 creates the House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications.
- Paragraph 2 sets membership: the Appropriations and Health committee chairs, three Speaker-appointed members or experts, and a Speaker-designated chairperson.
- Paragraph 3 charges the committee with studying PBM related issues and recommending action or legislation.
- Paragraph 5 details expense allowances, including a five-day cap on reimbursements unless additional days are authorized and funding from House appropriations.
- Paragraph 6 requires any approved report or, absent one, meeting minutes to be filed with the Clerk of the House before abolishment.
- Paragraph 7 abolishes the committee on December 1, 2026.
From the bill
“The committee shall stand abolished on December 1, 2026.”
Status timeline
- House Passed/Adopted By Substitute (House)
- House Third Readers (House)
- House Committee Favorably Reported By Substitute (House)
- House Second Readers (House)
- House First Readers (House)
- House Hopper (House)
Sponsors
- Ron Stephens (R, HD-164)
- Trey Kelley (R, HD-016)
- Lee Hawkins (R, HD-027)
- Debbie Buckner (D, HD-137)
- Mark Newton (R, HD-127)
Votes
- House voteMarch 9, 2026
157 yea, 0 nay (3 not voting, 17 absent)
Topics
- pharmacy benefits managers
- prescription drug costs
- health policy
- independent pharmacies
- legislative study committee